Wegovy vs Mounjaro: Complete Dose Comparison Guide
Understanding Wegovy Doses vs Mounjaro Escalation Schedules
The doses of wegovy follow a structured five-step escalation from 0.25mg to 2.4mg over 16 weeks, designed to minimise gastrointestinal side effects whilst optimising therapeutic benefits. Wegovy uses semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone to reduce appetite and promote satiety after smaller meals. Mounjaro employs tirzepatide, which activates both GIP and GLP-1 receptors, starting at 2.5mg and escalating through six doses up to 15mg over 20 weeks. This dual-receptor approach may offer enhanced appetite control, though both medications require prescription-only access following clinical assessment.
The practical implications of these different dosing schedules affect your treatment timeline and injection frequency. Wegovy doses reach maintenance strength at week 17, whilst Mounjaro's protocol extends to week 21 before achieving the highest available dose. Both medications are administered once weekly via pre-filled injection pens, with dose escalation being mandatory rather than optional to ensure optimal tolerability. Your prescriber will determine the most appropriate medication based on your medical history, current medications, and individual response to treatment alongside a reduced-calorie diet and increased physical activity.
Wegovy Doses Pricing vs Mounjaro Cost Analysis
Our transparent pricing for doses of wegovy starts with the 0.25mg starter dose at £79.99, progressing through 0.5mg (£94.99), 1mg (£99.99), 1.7mg (£139.99), to the 2.4mg maintenance dose at £209.99. New customers benefit from discount code FIRST40 applied at checkout, whilst returning customers use code DOSE25 for ongoing savings. Our Getting Started bundles provide convenient multi-dose packages, such as the Intro Duo (0.25mg & 0.5mg) for £169.99, eliminating the need for separate orders during your initial escalation phase. Mounjaro pricing follows a different structure reflecting its higher dose strengths and dual-receptor mechanism.
Bundle options offer Reliable Supply continuity without the hassle of monthly reordering. Our Progress Trio (0.5mg, 1mg & 1.7mg) provides three months of treatment for £369.99, whilst the Ultimate Stability Trio offers three 2.4mg maintenance pens for £649.99. These bundles ensure you maintain consistent treatment without supply interruptions, particularly important given the structured nature of dose escalation protocols. Both Wegovy and Mounjaro are available through our streamlined ordering process, with prices clearly displayed before checkout and discount codes automatically reducing your final payment amount.
Clinical Evidence for Wegovy Doses Effectiveness
The STEP clinical trial programme demonstrates the effectiveness of wegovy doses across diverse patient populations. In clinical trials, patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks in the STEP 1 study (Wilding et al., NEJM, 2021). The STEP 2 trial specifically examined patients with type 2 diabetes, showing approximately 9.6% weight reduction, whilst STEP 3 combined Wegovy with intensive behavioural therapy for approximately clinically studied weight loss. These results reflect the full dose escalation protocol from 0.25mg through to 2.4mg maintenance dosing.
Long-term sustainability data from STEP 5 demonstrates that clinical benefits may be maintained at two years with approximately 15.2% sustained weight loss. The recent SELECT cardiovascular outcomes trial revealed a 20% reduction in major cardiovascular events, highlighting potential benefits beyond weight management. Mounjaro's clinical programme shows different efficacy patterns due to its dual-receptor mechanism, though direct comparison between trial results isn't appropriate given different study designs and patient populations. Both medications require ongoing treatment, as discontinuation studies suggest patients may regain approximately two-thirds of lost weight within one year of stopping treatment.
How Wegovy Doses Work in Your Body
Understanding how doses of wegovy function helps explain the gradual escalation schedule from 0.25mg to 2.4mg over 16 weeks. Wegovy contains semaglutide, a GLP-1 receptor agonist that binds to receptors in your brain's appetite control centres, particularly the hypothalamus. This binding action slows gastric emptying, meaning food stays in your stomach longer, promoting feelings of fullness after smaller portions. The medication also influences reward pathways in the brain, potentially reducing food cravings and the desire for high-calorie foods. As doses increase from 0.25mg through to the 2.4mg maintenance level, these appetite-suppressing effects typically become more pronounced, supporting sustainable eating habit changes when combined with lifestyle modifications.
Ordering Wegovy Doses Through EverydayMeds
Our streamlined ordering process for doses of wegovy begins with a comprehensive three-minute online clinical assessment covering your medical history, current medications, and weight management goals. This information is reviewed by our qualified prescribers, with standard review times of three working days or express 24-hour service for urgent requirements. Once approved, your Wegovy doses are dispatched via next-day delivery using temperature-controlled cold-chain logistics to maintain medication integrity. Our GPhC-registered pharmacy (#9012878) ensures full regulatory compliance throughout the supply chain. Payment is processed securely at checkout, with discount codes FIRST40 (new customers) or DOSE25 (returning customers) automatically applied to reach our competitive pricing structure.
Storage and Practical Considerations for Wegovy Doses
Proper storage of wegovy doses requires refrigeration between 2-8°C before first use, with each pen remaining effective for up to 6 weeks at room temperature below 30°C once removed from the fridge. This storage flexibility provides significant advantages over Mounjaro, which maintains stability for only 21 days at room temperature, making Wegovy more suitable for travel or lifestyle situations where refrigeration isn't consistently available. The FlexTouch pen design enables straightforward once-weekly administration, with dose escalation preventing you from skipping steps in the protocol. Each pen contains four doses, meaning the 0.25mg starter pen lasts exactly four weeks before progressing to the 0.5mg strength. Unused pens should be stored in original packaging to protect from light, and you should never freeze the medication or use it if accidentally frozen.
Wegovy vs Mounjaro Dose Escalation Timeline Comparison
The doses of wegovy follow a more compact escalation schedule compared to Mounjaro's extended protocol, reaching maintenance dosing four weeks earlier. Wegovy's five-dose progression (0.25mg, 0.5mg, 1mg, 1.7mg, 2.4mg) spans 16 weeks, whilst Mounjaro's six-dose schedule (2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, 15mg) extends over 20 weeks. This difference affects both your treatment timeline and injection scheduling, with Wegovy patients reaching therapeutic maintenance doses sooner. The practical implications include fewer dose transitions and potentially faster progress towards optimal appetite control effects.
Both medications require careful adherence to their respective escalation schedules, as skipping doses or advancing too quickly may increase side effects or reduce therapeutic benefits. Your prescriber will monitor your response at each dose level, potentially extending time at particular strengths if needed for optimal tolerability. The choice between Wegovy's shorter escalation and Mounjaro's extended protocol depends on individual factors including previous medication responses, existing health conditions, and personal preferences regarding treatment duration before reaching maintenance dosing.
Complete Treatment Support for Wegovy Doses
Selecting the appropriate doses of wegovy involves comprehensive support from our clinical team throughout your weight management journey. Our prescribers provide guidance on dose escalation timing, side effect management, and integration with dietary and exercise modifications required for optimal outcomes. This ongoing clinical support ensures you understand each transition from 0.25mg through to 2.4mg maintenance, with clear instructions for injection technique and storage requirements. Both Wegovy and Mounjaro are available through our service, allowing flexibility if your prescriber determines an alternative approach would better suit your clinical needs. Regular review appointments help monitor progress and adjust treatment plans as required, ensuring you receive personalised care throughout your prescription-only medicine therapy. Visit our weight loss collection at https://everydaymeds.co.uk/collections/weight-loss to begin your clinical assessment, with discount codes FIRST40 or DOSE25 applied automatically at checkout to deliver competitive pricing on both treatment options.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
